Conrad Wai, CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 300,000 shares at $4.72 ($1.4M) on 2026-09-15, disclosed to the SEC on 2026-09-16.
Scheduled sale ($1.4M) by CEO, Counterpart Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLOV | SELL | 2025-07-24 | $996K | — | Filing → |
| CLOV | SELL | 2025-07-10 | $50K | — | Filing → |